BioSpace News Archive

Business

Bovie Medical Corporation Announces Appointment of Laura Iversen as Director of Global Operations for Advanced Energy

Bovie Medical is a medical technology company and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market.

October 22, 2018
·
4 min read
Drug Development

Pancreatology Publishes Results of the PANOVA Phase 2 Pilot Trial in Advanced Pancreatic Cancer Suggesting Improved Survival of Patients Treated with Tumor Treating Fields

The Tumor Treating Fields plus gemcitabine and nab-paclitaxel patient cohort showed progression free and one-year survivals that were more than double those of the gemcitabine and nab-paclitaxel-treated historical control

October 22, 2018
·
5 min read
Business

Naveris Congratulates Scientific Advisors Bhisham Chera and Gaorav Gupta on Presentation of Clinical Data at the 2018 ASTRO Annual Meeting

Naveris, Inc., a private biotechnology company developing blood tests for early cancer detection, congratulates Bhisham Chera, M.D. and Gaorav Gupta, M.D., Ph.D.,

October 22, 2018
·
1 min read
Biotech Beach

Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections

Qpex Biopharma today announced the closing of a $33 million Series A financing and launch of the infectious disease company.

October 22, 2018
·
3 min read
Business

MGMA Announces 2018-2019 Board of Directors

A group of men and women with diverse backgrounds and expertise that will help further drive the organization’s mission to create meaningful change in the healthcare industry.

October 22, 2018
·
4 min read
Biotech Bay

Genomic Health Announces Multiple Studies Reinforcing Value of Oncotype DX® Tests in Guiding Treatment for Breast and Prostate Cancer Patients

Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple studies of its Oncotype DX® tests highlighting their value in optimizing treatment for patients with various stages of breast and prostate cancer.

October 22, 2018
·
9 min read
Drug Development

Theravance Biopharma Reports Data from TD-1473 Phase 1b Four-Week Study in Oral Late-Breaker Presentation at UEG Week 2018

Presented Data Demonstrated Signals of Clinical and Biomarker Activity

October 22, 2018
·
12 min read
Pharm Country

Actinium Pharmaceuticals Announces Webinar Showcasing Actimab-A Post Phase 2 Trial Plans and Actimab-MDS Regulatory Update

Dr. Gary Schiller, Professor of Medicine, Hematology-Oncology at UCLA Medical Center and Dr. Tapan Kadia, Associate Professor of Medicine, at MD Anderson Cancer Center to highlight post Phase 2 development plans for Actimab-A

October 22, 2018
·
8 min read
Pharm Country

Formativ Health Improves Patient-Provider Compatibility and Communication with Integration of XpertDox

Formativ Health, a technology-enabled health services company focused on transforming the patient-provider experience, announced today the integration of XpertDox into its innovative Patient Engagement Platform (PEP)

October 22, 2018
·
4 min read
Patient-Data Platform Raremark Raises £3m to Enable Precision Medicine in Rare Disease

The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments.

October 22, 2018
·
5 min read